Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
EPS (Basic)EPS (Weighted Average and Diluted)Interest & Investment IncomeInterest ExpensesInterest ExpensesNon Operating IncomeOperating ExpensesProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Nautilus Biotechnology (NAUT) Non Operating Income (2020 - 2026)

Nautilus Biotechnology has reported Non Operating Income over the past 7 years, most recently at $1.4 million for Q1 2026.

  • Quarterly results put Non Operating Income at $1.4 million for Q1 2026, down 36.04% from a year ago — trailing twelve months through Mar 2026 was $7.0 million (down 30.03% YoY), and the annual figure for FY2025 was $7.8 million, down 26.74%.
  • Non Operating Income reached $1.4 million in Q1 2026 per NAUT's latest filing, down from $1.6 million in the prior quarter.
  • Across five years, Non Operating Income topped out at $3.2 million in Q2 2023 and bottomed at -$132000.0 in Q3 2022.
  • Median Non Operating Income over the past 5 years was $2.4 million (2024), compared with a mean of $2.1 million.
  • The largest annual shift saw Non Operating Income tumbled 83.33% in 2022 before it skyrocketed 45728.57% in 2023.
  • Over 5 years, Non Operating Income stood at $2.9 million in 2022, then grew by 2.83% to $3.0 million in 2023, then decreased by 19.85% to $2.4 million in 2024, then crashed by 31.14% to $1.6 million in 2025, then fell by 13.15% to $1.4 million in 2026.
  • Business Quant data shows Non Operating Income for NAUT at $1.4 million in Q1 2026, $1.6 million in Q4 2025, and $1.9 million in Q3 2025.